CD19 CD19抗体

Quantity size: 50ul
Concentration: 1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background: CD19 is a transmembrane glycoprotein that is delectively expressed on the cell surface of B-lymphocytes,where it activates intracellular signaling cascades involving both Ras and phosphatidylinositol 3-kinase pathways.Lymphocytes proliferate and differentiate in response to various concentrations of different antigens. The ability of the B cell to respond in a specific, yet sensitive manner to the various antigens is achieved with the use of low-affinity antigen receptors. This gene encodes a cell surface molecule which assembles with the antigen receptor of B lymphocytes in order to decrease the threshold for antigen receptor-dependent stimulation.
Also known as: Antibody deficiency due to defect in CD19, included; AW495831; B lymphocyte antigen CD19; B lymphocyte surface antigen B4; B4; CD 19; CD19 antigen; CD19 molecule; Cd19 protein; Differentiation Antigen CD19; Leu 12; Leu12; Lymphocyte Surface Antigen; MGC109570; MGC12802; T-cell surface antigen Leu-12.
Specificity: 1 Rabbit Polyclonal IgG, affinity purified by Protein A.
2 Reacts with: Human, Mouse, Rat, Pig, Guinea Pig, .
3 Immunogen: KLH conjugated synthetic peptide derived from human CD19 (171-220aa).
4 Predicted Molecular Weight: 59kDa.Storage: Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles). Application: WB=1:500-2000 ELISA=1:500-1000 IHC-P=1:400-800 IHC-F=1:100-500 Flow-Cyt=1μg /Test ICC=1:100-500 IF=1:50-200

Not yet tested in other applications.

Optimal working dilutions must be determined by the end user. Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.